# A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

> **NCT06866977** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 10 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Oncolytic virus VRT106
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06866977
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-12
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06866977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06866977, "A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06866977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*